Literature DB >> 4856884

A model of the kinetics of insulin in man.

R S Sherwin, K J Kramer, J D Tobin, P A Insel, J E Liljenquist, M Berman, R Andres.   

Abstract

The design of the present study of the kinetics of insulin in man combines experimental features which obviate two of the major problems in previous insulin studies. (a) The use of radioiodinated insulin as a tracer has been shown to be inappropriate since its metabolism differs markedly from that of the native hormone. Therefore porcine insulin was administered by procedures which raised insulin levels in arterial plasma into the upper physiologic range. Hypoglycemia was prevented by adjusting the rate of an intravenous infusion of glucose in order to control the blood glucose concentration (the glucose-clamp technique). (b) Estimation of a single biological half-time of insulin after pulse injection of the hormone has been shown to be inappropriate since plasma insulin disappearance curves are multiexponential. Therefore the SAAM 25 computer program was used in order to define the parameters of a three compartment insulin model. The combined insulin mass of the three compartments (expressed as plasma equivalent volume) is equal to inulin space (15.7% body wt). Compartment 1 is apparently the plasma space (4.5%). The other two compartments are extra-vascular; compartment 2 is small (1.7%) and equilibrates rapidly with plasma, and compartment 3 is large (9.5%) and equilibrates slowly with plasma. The SAAM 25 program can simulate the buildup and decay of insulin in compartments 2 and 3 which cannot be assayed directly. Insulin in compartment 3 was found to correlate remarkably with the time-course of the servo-controlled glucose infusion. Under conditions of a steady-state arterial glucose level, glucose infusion is a measure of glucose utilization. We conclude that compartment 3 insulin (rather than plasma insulin) is a more direct determinant of glucose utilization. We suggest that the combined use of glucose-clamp and kinetic-modeling techniques should aid in the delineation of pathophysiologic states affecting glucose and insulin metabolism.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4856884      PMCID: PMC302637          DOI: 10.1172/JCI107697

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  INHIBITION BY INSULIN OF HEPATIC GLUCOSE PRODUCTION IN THE NORMAL DOG.

Authors:  R STEELE; J S BISHOP; A DUNN; N ALTSZULER; I RATHBEB; R C DEBODO
Journal:  Am J Physiol       Date:  1965-02

2.  Morphological classifications of vertebrate blood capillaries.

Authors:  H S BENNETT; J H LUFT; J C HAMPTON
Journal:  Am J Physiol       Date:  1959-02

3.  Evidence for an insulin-induced inhibition of insulin release by isolated islets of Langerhans.

Authors:  J C Sodoyez; F Sodoyez-Goffaux; P P Foà
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

4.  Aging and diabetes.

Authors:  R Andres
Journal:  Med Clin North Am       Date:  1971-07       Impact factor: 5.456

5.  A semiautomated technic for radioimmunoassay. Double antibody assay of insulin.

Authors:  M L Haas; L Shenkman; P Weissman; R Andres
Journal:  Diabetes       Date:  1970-02       Impact factor: 9.461

Review 6.  Hepatic vascular bed.

Authors:  C V Greenway; R D Stark
Journal:  Physiol Rev       Date:  1971-01       Impact factor: 37.312

7.  Derivation of a three compartment model describing disappearance of plasma insulin-131-I in man.

Authors:  A Silvers; R S Swenson; J W Farquhar; G M Reaven
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

8.  Insulin delivery rate into plasma in normal and diabetic subjects.

Authors:  M P Stern; J W Farquhar; A Silvers; G M Reaven
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

9.  Insulin fixation and glucose uptake by forearm tissues in response to infusions of physiological amounts of insulin in non-diabetic subjects.

Authors:  E Rasio; M J Whichelow; W J Butterfield; B H Hicks
Journal:  Diabetologia       Date:  1972-08       Impact factor: 10.122

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

View more
  116 in total

1.  Insulin activation of plasma nonesterified fatty acid uptake in metabolic syndrome.

Authors:  Maria A Ramos-Roman; Smadar A Lapidot; Robert D Phair; Elizabeth J Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

2.  Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans.

Authors:  S N Davis; C Shavers; F Costa; R Mosqueda-Garcia
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Insulin clearance is different in men and women.

Authors:  Michael D Jensen; Soren Nielsen; Nidhi Gupta; Rita Basu; Robert A Rizza
Journal:  Metabolism       Date:  2011-10-13       Impact factor: 8.694

4.  Bolus Estimation--Rethinking the Effect of Meal Fat Content.

Authors:  Srinivas Laxminarayan; Jaques Reifman; Stephanie S Edwards; Howard Wolpert; Garry M Steil
Journal:  Diabetes Technol Ther       Date:  2015-08-13       Impact factor: 6.118

5.  Insulin entry into muscle involves a saturable process in the vascular endothelium.

Authors:  S Majumdar; A J Genders; A C Inyard; V Frison; E J Barrett
Journal:  Diabetologia       Date:  2011-10-15       Impact factor: 10.122

Review 6.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

7.  Separation of physiological factors influencing glucose-insulin kinetics in diabetic patients.

Authors:  B G Min; E J Woo; H K Lee; H K Min
Journal:  Ann Biomed Eng       Date:  1985       Impact factor: 3.934

8.  Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man.

Authors:  L A Frohman; J L Thominet; C B Webb; M L Vance; H Uderman; J Rivier; W Vale; M O Thorner
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

Review 9.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Beta-adrenergic blockade is more effective in suppressing adrenaline-induced glucose production in Type 1 (insulin-dependent) diabetes.

Authors:  H Shamoon; R Sherwin
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.